Status:

COMPLETED

Effect of Home Rehabilitation on State of Patients With PAH, HFREF and IHD

Lead Sponsor:

Medical University of Bialystok

Conditions:

Pulmonary Hypertension

Heart Failure With Reduced Ejection Fraction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the study is to evaluate the influence of physical training and respiratory rehabilitation performed by patients at home on quality of life, symptoms, physical endurance, force of respirato...

Detailed Description

The study will be conducted on total group of 100 participants, from which 75 will be the patients with PAH (pulmonary arterial hypertension), HF-REF (heart failure with reduced ejection fraction) or ...

Eligibility Criteria

Inclusion

  • age \>18 years
  • informed consent signed by patient to conduct the study
  • no diseases excluding rehabilitation
  • pts with idiopathic, inherited PAH (pulmonary arterial hypertension), or in the course of connective tissue diseases, portal hypertension, congenital heart diseases.
  • PAH confirmed in catheterisation of right side of heart mPAP (mean pulmonary arterial pressure) ≥25 mmHg, PCWP (pulmonary capillary wedge pressure) ≤15mmHg.
  • Chronic heart failure - left ventricle ejection fraction \<40% in echocardiography, NYHA \*New York Health Association) class II-III
  • stable ischaemic heart disease in CCS (Canadian Cardiovascular Society) class II-III

Exclusion

  • Other types of pulmonary hypertension
  • COPD (chronic obstructive pulmonary disease), asthma
  • malignancies
  • Acute inflammatory state up to 4 weeks before inclusion to the study
  • Acute coronary syndrome up to 3 months before inclusion to the study
  • Heart failure in NYHA IV class
  • severe anaemia (Hgb \<11g/dl for men \<10g/dl for women)
  • electrolyte and hormonal disturbances in period of 1 month before inclusion to the study
  • substantial modification of treatment of main disease within last 3 months
  • ischaemic heart disease in CCS class IV
  • Other clinical situations excluding to perform controlled program of rehabilitation

Key Trial Info

Start Date :

February 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2021

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT03780803

Start Date

February 1 2016

End Date

September 30 2021

Last Update

November 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of Bialystok, Department of Rehabilitation

Bialystok, Podlaskie Voivodeship, Poland, 15-089